Colinz Laboratories Claims SEBI LODR Regulation 15(2) Exemption

Regulatory Basis for Exemption

The company claims exemption under Regulation 15(2)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Specifically, the company states that compliance with provisions specified in Regulations 17 to 27, Clauses (b) to (i) and (t) of sub-regulation (2) of Regulation 46, and paragraphs C, D and E of Schedule V of the SEBI (LODR) Regulations, 2015 are not applicable to the company.

Specific Disclosure Relief

As a result of this exemption, the company confirms it is not required to submit Related Party Transaction disclosures as mandated under Regulation 23(9) of the SEBI (LODR) Regulations, 2015 for the quarter ended 30th June, 2026.